Navigating a metastatic castration-resistant prostate cancer (mCRPC) diagnosis while preserving self-identity can feel like ...

Led by former Novartis executive Emanuele Ostuni, the startup has a prostate cancer medicine advancing into early clinical ...

New insights highlight how prostate cancer is now managed as a chronic disease, with emerging treatments and real-world data ...

Telix Pharmaceuticals' strong sales, diverse pipeline, and theranostics promise support a Buy rating, despite SEC concerns.

New Jersey-based drugmaker Bristol Myers Squibb this month dedicated its first production facility in Indiana, a former north ...

I expected that becoming cancer-free would mean getting my old life back. Nothing could be further from the truth.

In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how ...

University of Michigan researchers identified a gene program associated with extreme non-response to the cancer drug ...

Human cancer is a complex and heterogeneous group of diseases characterized by uncontrolled cell growth and proliferation. Post-translational modifications (PTMs) of proteins play a critical role in ...

The firm will test gedatolisib as a first-line treatment in patients with HR-positive, HER2-negative advanced breast cancer who are endocrine therapy resistant.